Previous Close | 2.8700 |
Open | 3.1475 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 3.0700 - 3.2824 |
52 Week Range | 2.4000 - 11.7700 |
Volume | |
Avg. Volume | 24,571 |
Market Cap | 3.631M |
Beta (5Y Monthly) | 1.38 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -12.9700 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 20.00 |
BERWYN, Pa., March 26, 2024--Virpax Reports 2023 Year-End Results
BERWYN, Pa., February 27, 2024--Virpax Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price
BERWYN, Pa., February 27, 2024--Virpax Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.